Equivalent drug efficacy issue implicated in different interests of related groups.

Published: 1999-09-07 10:09:00

Updated: 1999-09-07 10:09:00

The equivalent drug efficacy issue has been disputed without any chances of optimistic resolution probably because of its different interests among related organizations, the pharmacist, the medical and the government communities. The new medical and pharmacy separation system allows pharmacists ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK